Coya Therapeutics Files Form 4
Ticker: COYA · Form: 4 · Filed: Apr 9, 2026 · CIK: 0001835022
| Field | Detail |
|---|---|
| Company | Coya Therapeutics, Inc. (COYA) |
| Form Type | 4 |
| Filed Date | Apr 9, 2026 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: insider-filing, ownership-change
TL;DR
Coya Therapeutics insider trading update filed today.
AI Summary
On April 9, 2026, Coya Therapeutics, Inc. filed a Form 4, indicating changes in beneficial ownership of securities. The filing details transactions related to the company's stock, with specific changes to be detailed within the document.
Why It Matters
Form 4 filings are crucial for investors as they disclose changes in stock ownership by company insiders, providing insights into their confidence in the company's prospects.
Risk Assessment
Risk Level: medium — Form 4 filings can indicate insider confidence or divestment, which may impact stock price.
Key Players & Entities
- Coya Therapeutics, Inc. (company) — Issuer
- 0001835022 (company) — Issuer CIK
- 2026-04-09 (date) — Period of Report
- Pavao Mark H (person) — Reporting Person
- 0001297988 (person) — Reporting Person CIK
FAQ
What type of filing is this?
This is a Form 4 filing, a Statement of changes in beneficial ownership of securities.
Who is the issuer?
The issuer is Coya Therapeutics, Inc. (CIK: 0001835022).
When was the period of report for this filing?
The period of report was April 9, 2026.
What is the SEC Accession Number for this filing?
The SEC Accession Number is 0001193125-26-149968.
What is the business address of Coya Therapeutics, Inc.?
The business address is 12645 MEMORIAL DR., SUITE F1 #305 HOUSTON TX 77024.
Filing Details
This Statement of Changes in Beneficial Ownership (Form 4) was filed with the SEC on April 9, 2026 by Pavao Mark H regarding Coya Therapeutics, Inc. (COYA). Form 4 filings disclose purchases, sales, or other changes in ownership by company insiders such as officers, directors, and major shareholders.